Analysis of cell proliferation and cell death during in situ hyperthermic treatment of neoplastic cells: a case report of human non-Hodgkin lymphoma
/in Hyperthermia, International Publications, Malignant Lymphoma /von 2006-05-24 / Biomed. Pharmacother. 2006 Jun;60(5):227-32Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients
/in International Publications, Malignant Melanoma /von 2006-05-15 / Int. J. Cancer 2006 May;118(10):2617-27Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy
/in Chronic Virus Hepatitis, International Publications /von 2006-05-15 / J. Immunol. 2006 May;176(10):6065-75Virology- and immunology-based gene therapy for cancer
/in Dendritic Cells, International Publications /von 2006-05-12 / Cancer Immunol. Immunother. 2006 Nov;55(11):1420-5Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
/in International Publications, Malignant Melanoma /von 2006-05-05 / Cancer Gene Ther. 2006 Oct;13(10):905-18Pure sarcomatous recurrence of clear cell renal carcinoma following radical nephrectomy and dendritic cell vaccination
/in Hypernephroma, International Publications /von 2006-05-04 / Sao Paulo Med J 2006 May;124(3):161-2A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-25Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer
/in Breast Cancer, International Publications /von 2006-05-01 / Int. J. Cancer 2006 May;118(9):2220-31Targeting tumours by adoptive transfer of immune cells
/in Breast Cancer, International Publications /von 2006-05-01 / Clin. Exp. Pharmacol. Physiol. 2006 May-Jun;33(5-6):569-74
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution